Table 2.

Freedom from peripheral arterial revascularization in statin‐treated patients with high cardiovascular risk and elevated triglycerides vs comparators (Kaplan‐Meier analysis)

Cohort	0.5 Year	1 Year	2 Years	3 Years	4 Years	5 Years	Clustered P‐value
Elevated triglyceridesa	0.9873 (2 2795)	0.9783 (1 9265)	0.9637 (1 4678)	0.9525 (1 1723)	0.9420 (7942)	0.9308 (6096)	<.001
Comparatorb	0.9913 (2 2884)	0.9849 (1 9566)	0.9752 (1 5149)	0.9652 (1 2319)	0.9574 (8514)	0.9512 (6664)

Values represent probability of freedom from peripheral arterial revascularization (number of patients at risk). Clustered P‐value was calculated using Cox proportional hazard model with cohort as independent variable.

^aElevated triglycerides cohort: triglycerides ≥150 mg/dL.

^bComparator cohort: triglycerides <150 mg/dL and high‐density lipoprotein cholesterol >40 mg/dL.